[Monokine production by mouse peritoneal macrophages after phagocytosis of mycobacteria].

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Nihon Rai Gakkai zasshi

• Publication date

  1992-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5025/HANSEN1977.61.92PMID 1487453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.

  1991cited by this paper
• Tumor necrosis factor.

  1991cited by this paper
• Interleukin-1 and its biologically related cytokines.

  1989cited by this paper
• The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

  1989cited by this paper
• Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages.

  1989cited by this paper
• Transmembrane signaling during interleukin 1-dependent T cell activation. Interactions of signal 1- and signal 2-type mediators with the phosphoinositide-dependent signal transduction mechanism.

  1987cited by this paper
• Cachectin and tumour necrosis factor as two sides of the same biological coin

  1986cited by this paper
• There is more than one interleukin 1.

  1986cited by this paper
• Tumor necrosis factor (TNF).

  1985cited by this paper
• Role of interleukin 1 in experimental pulmonary granuloma in mice.

  1985cited by this paper
• Human tumor necrosis factor.

  1985cited by this paper
• Interleukin 1 is more than an interleukin.

  1982cited by this paper
• Production of an antibody against guinea pig MIF. III. Biological activity of MIF recovered from immunoadsorbent column chromatography.

  1981cited by this paper
• Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.

  1981cited by this paper
• Mechanism of action of macrophage-derived suppressor factor produced by soluble immune response suppressor-treated macrophages.

  1981cited by this paper
• Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.

  1981cited by this paper
• Macrophage Activation by Muramyl Dipeptide as Measured by Macrophage Spreading and Attachment

  1980cited by this paper
• Lack of responsiveness of C3H/HeJ macrophages to lipopolysaccharide: the cellular basis of LPS-stimulated metabolism.

  1979cited by this paper
• Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.

  1979cited by this paper
• Physicochemical characterization of lymphocyte-activating factor (LAF).

  1979cited by this paper
• The Activation of Macrophages by Lymphokines

  1979cited by this paper
• Heterocytolysis by Macrophages Activated by Bacillus Calmette-Gu�rin: Lysosome Exocytosis into Tumor Cells

  1974cited by this paper

• Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.

  2004cites this paper
• IL-10 treatment of macrophages bolsters intracellular survival of Mycobacterium leprae.

  2004cites this paper
• Down regulation of Ia expression in macrophages following incubation with mycobacteria.

  1994cites this paper
• Clofazimine-mediated augmentation of LPS-induced tumor necrosis factor production in macrophages.

  1994cites this paper